Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets

por Schweppe, Rebecca E.
Publicado 2012

Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion

por Bauerle, Kevin T, Schweppe, Rebecca E, Haugen, Bryan R
Publicado 2010

SAT-574 Elucidating the Role of Nuclear Focal Adhesion Kinase (FAK) in Thyroid Cancer

por Kellett, Meghan, Kessler, Brittelle, Mishall, Katie, Sharma, Vibha, Schweppe, Rebecca
Publicado 2019

Integrating heterogeneous drug sensitivity data from cancer pharmacogenomic studies

por Pozdeyev, Nikita, Yoo, Minjae, Mackie, Ryan, Schweppe, Rebecca E., Tan, Aik Choon, Haugen, Bryan R.
Publicado 2016

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity

por Bolf, Eric L., Beadnell, Thomas C., Rose, Madison M., D’Alessandro, Angelo, Nemkov, Travis, Hansen, Kirk C., Schweppe, Rebecca E.
Publicado 2023

Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer

por Mishall, Katie M., Beadnell, Thomas C., Kuenzi, Brent M., Klimczak, Dorothy M., Superti-Furga, Giulio, Rix, Uwe, Schweppe, Rebecca E.
Publicado 2017

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells

por Wood, William M., Sharma, Vibha, Bauerle, Kevin T., Pike, Laura A., Zhou, Qiong, Fretwell, Deborah L., Schweppe, Rebecca E., Haugen, Bryan R.
Publicado 2011

Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer

por Beadnell, Thomas C., Nassar, Kelsey W., Rose, Madison M., Clark, Erin G., Danysh, Brian P., Hofmann, Marie-Claude, Pozdeyev, Nikita, Schweppe, Rebecca E.
Publicado 2018

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

por Kessler, Brittelle E., Mishall, Katie M., Kellett, Meghan D., Clark, Erin G., Pugazhenthi, Umarani, Pozdeyev, Nikita, Kim, Jihye, Tan, Aik Choon, Schweppe, Rebecca E.
Publicado 2018

BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer

por Rose, Madison M., Espinoza, Veronica L., Hoff, Katelyn J., Pike, Laura A., Sharma, Vibha, Hofmann, Marie-Claude, Tan, Aik Choon, Pozdeyev, Nikita, Schweppe, Rebecca E.
Publicado 2023

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

por Chatterji, Tanushree, Varkaris, Andreas S., Parikh, Nila U., Song, Jian H., Cheng, Chien-Jui, Schweppe, Rebecca E., Alexander, Stephanie, Davis, John W., Troncoso, Patricia, Friedl, Peter, Kuang, Jian, Lin, Sue-Hwa, Gallick, Gary E.
Publicado 2015